Grant Avenue Capital has announced it has participated in a recapitalization of CREO with founding partners of the company.
CREO, founded in 2015 and based in Durham, N.C., is a provider of strategy, merger and acquisition, digital transformation, cybersecurity, information technology quality and regulatory compliance consulting services to life sciences and healthcare organizations/
Grant Avenue Capital, based in New York, is a healthcare-focused, middle market private equity firm. Founded in 2017, the firm generally targets companies with approximately $5 million to $25 million of EBITDA and pursues control buyouts, buy-and-builds, corporate carve-outs, joint-control partnership investments and special situations.
Terms of the investment were not disclosed.
